A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes.
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 03 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2009 New trial record